AptarGroup, Inc.
General ticker "ATR" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $8.6B (TTM average)
AptarGroup, Inc. does not follow the US Stock Market performance with the rate: -18.0%.
Estimated limits based on current volatility of 1.5%: low 129.94$, high 134.02$
Factors to consider:
- Earnings expected soon, date: 2026-07-30 amc
- Company pays dividends (quarterly): last record date 2026-05-06, amount 0.48$ (Y1.45%)
- Total employees count: 14000 (+3.7%) as of 2025
- North America accounted for 32.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Supply chain disruptions, Geopolitical risks, Cybersecurity threats, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [98.76$, 143.83$]
- 2026-12-31 to 2027-12-31 estimated range: [103.73$, 148.70$]
Financial Metrics affecting the ATR estimates:
- Negative: with PPE of 21.4 at the end of fiscal year the price was high
- Positive: 6.62 < Operating cash flow per share per price, % of 7.07
- Positive: 7.57 < Operating profit margin, % of 13.26
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.95 > 6.02
- Positive: 42.57 < Shareholder equity ratio, % of 50.79 <= 64.23
- Positive: Interest expense per share per price, % of 0.65 <= 0.74
- Positive: -9.70 < Industry operating profit margin (median), % of -3.62
Short-term ATR quotes
Long-term ATR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3,487.45MM | $3,582.89MM | $3,777.18MM |
| Operating Expenses | $3,083.43MM | $3,086.39MM | $3,276.14MM |
| Operating Income | $404.02MM | $496.50MM | $501.04MM |
| Non-Operating Income | $-29.19MM | $-26.73MM | $-9.66MM |
| Interest Expense | $40.42MM | $43.90MM | $52.74MM |
| Income(Loss) | $374.82MM | $469.76MM | $491.38MM |
| Taxes | $90.65MM | $95.59MM | $98.88MM |
| Net Income(Loss)* | $284.49MM | $374.54MM | $392.79MM |
| Stockholders Equity | $2,306.82MM | $2,471.89MM | $2,668.10MM |
| Inventory | $513.05MM | $461.81MM | $537.85MM |
| Assets | $4,451.89MM | $4,432.28MM | $5,252.72MM |
| Operating Cash Flow | $575.24MM | $643.41MM | $570.00MM |
| Capital expenditure | $318.40MM | $294.19MM | $270.42MM |
| Investing Cash Flow | $-324.46MM | $-396.72MM | $-331.43MM |
| Financing Cash Flow | $-171.55MM | $-225.34MM | $-77.47MM |
| Earnings Per Share** | $4.34 | $5.65 | $5.97 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.